The Intramuscular Vaccine Adjuvants Market is estimated to be valued at US$ 650.6 million in 2022 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:
Intramuscular vaccine adjuvants are substances that are added to vaccines to enhance their immune response and efficacy. These vaccine...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian